Sept 21 (Reuters) - Advicenne ALDVI.PA :
* H1 REVENUES EUR 1.9 MILLION VERSUS EUR 1.7 MILLION YEAR
AGO
* H1 OPERATING LOSS EUR 4.4 MILLION VERSUS LOSS EUR 7.5
MILLION
YEAR AGO
* H1 NET LOSS EUR 4.8 MILLION VERSUS LOSS EUR 8.0 MILLION
YEAR AGO
* AT END-JUNE, CASH AND CASH EQUIVALENT STOOD AT EUR 7.29
MILLION
* WITH OVER 75 HOSPITALS ORDERING SIBNAYAL® IN EUROPE, WE
EXPECT
SALES TO SIGNIFICANTLY ACCELERATE IN H2
* AS OF DATE OF CURRENT PRESS RELEASE, FINANCIAL VISIBILITY
RUNS
THROUGH Q3 OF 2023
Source text for Eikon: ID:nBw5XKN1Ka
Further company coverage: [ ALDVI.PA ]
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))